Sebastien Gibot

Nancy, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.

A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.

Journal: Lupus

Published: November 14, 2025

Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial.

Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial.

Journal: Intensive care medicine

Published: March 10, 2025

Esophageal Achalasia: An Unusual Cause of Respiratory Distress.

Esophageal Achalasia: An Unusual Cause of Respiratory Distress.

Journal: Case reports in critical care

Published: November 27, 2024

Case Report: Extracorporeal Carbon Dioxide Removal in a Severely Brain-Injured Patient With Acute Respiratory Distress Syndrome.

Case Report: Extracorporeal Carbon Dioxide Removal in a Severely Brain-Injured Patient With Acute Respiratory Distress Syndrome.

Journal: Case reports in critical care

Published: October 17, 2024

Pseudomonas aeruginosa Infections in Patients with Severe COVID-19 in Intensive Care Units: A Retrospective Study.

Pseudomonas aeruginosa Infections in Patients with Severe COVID-19 in Intensive Care Units: A Retrospective Study.

Journal: Antibiotics (Basel, Switzerland)

Published: April 03, 2024

Implementation of a fluid balance control strategy in critically ill patients: POINCARE-2 trial process evaluation.

Implementation of a fluid balance control strategy in critically ill patients: POINCARE-2 trial process evaluation.

Journal: BMC medical research methodology

Published: January 01, 2024

Fluid balance control in critically ill patients: results from as-treated analyses of POINCARE-2 randomized trial.

Fluid balance control in critically ill patients: results from as-treated analyses of POINCARE-2 randomized trial.

Journal: Critical care (London, England)

Published: July 27, 2023

Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.

Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.

Journal: Frontiers in medicine

Published: May 18, 2023

Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients.

Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients.

Journal: Intensive care medicine experimental

Published: April 21, 2023

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.

Journal: EClinicalMedicine

Published: April 04, 2023

Hydrocortisone in Severe Community-Acquired Pneumonia.

Hydrocortisone in Severe Community-Acquired Pneumonia.

Journal: The New England journal of medicine

Published: March 21, 2023

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

Journal: The Lancet. Respiratory medicine

Published: January 30, 2023

Showing 1-12 of 106

Last Updated: 09/26/2026